Key points are not available for this paper at this time.
Longitudinal assessment of antibody response in African COVID-19 patients revealed heterogeneous responses. This underscores the need for a comprehensive evaluation of seroassays before implementation. Factors associated with failure to seroconvert needs further research.
Gebrecherkos et al. (Wed,) studied this question.